Free Trial

India Capital Growth (IGC) Competitors

India Capital Growth logo
GBX 172.04 +3.54 (+2.10%)
As of 08:14 AM Eastern

IGC vs. SLN, AMYT, BMY, GPH, ARTL, AURA, PHAR, KOD, ORPH, and AMPH

Should you be buying India Capital Growth stock or one of its competitors? The main competitors of India Capital Growth include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), Global Ports (GPH), Alpha Real Trust (ARTL), Aura Energy (AURA), Pharos Energy (PHAR), Kodal Minerals (KOD), Open Orphan (ORPH), and Aggregated Micro Power (AMPH). These companies are all part of the "pharmaceutical products" industry.

India Capital Growth vs. Its Competitors

India Capital Growth (LON:IGC) and Silence Therapeutics (LON:SLN) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

India Capital Growth has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than India Capital Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
India Capital Growth£25.86M5.68£43.14M£0.27636.22
Silence Therapeutics£11.35M0.00N/A-£48.60N/A

3.9% of India Capital Growth shares are held by institutional investors. 1.3% of India Capital Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, India Capital Growth had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for India Capital Growth and 0 mentions for Silence Therapeutics. India Capital Growth's average media sentiment score of 0.76 beat Silence Therapeutics' score of 0.00 indicating that India Capital Growth is being referred to more favorably in the media.

Company Overall Sentiment
India Capital Growth Positive
Silence Therapeutics Neutral

India Capital Growth has a net margin of 93.35% compared to Silence Therapeutics' net margin of 0.00%. India Capital Growth's return on equity of 25.12% beat Silence Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
India Capital Growth93.35% 25.12% 15.98%
Silence Therapeutics N/A N/A N/A

Summary

India Capital Growth beats Silence Therapeutics on 10 of the 10 factors compared between the two stocks.

Get India Capital Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IGC vs. The Competition

MetricIndia Capital GrowthAsset Management IndustryFinancial SectorLON Exchange
Market Cap£146.95M£1.45B£6.37B£2.56B
Dividend YieldN/A4.58%4.31%5.31%
P/E Ratio636.224,762.471,780.255,426.27
Price / Sales5.681,975.761,364.5397,351.62
Price / Cash97.3160.62127.5227.93
Price / Book0.871.382.089.25
Net Income£43.14M£265.04M£1.23B£5.89B
7 Day Performance2.71%0.29%0.95%0.50%
1 Month Performance0.02%1.26%2.09%44.45%
1 Year Performance-8.00%8.81%31.85%183.74%

India Capital Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IGC
India Capital Growth
N/AGBX 172.04
+2.1%
N/A-8.9%£146.95M£25.86M636.2261Positive News
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.2937 of 5 stars
GBX 495
-0.3%
GBX 825
+66.7%
-28.5%£403.32M£361M1,611.8534,300
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020News Coverage
ARTL
Alpha Real Trust
N/AN/AN/AN/A£113.12M£8.46M96.445Gap Up
High Trading Volume
AURA
Aura Energy
N/AGBX 11.56
+0.5%
N/A+82.1%£100.42MN/A-25,328.8050High Trading Volume
PHAR
Pharos Energy
N/AGBX 21.50
+0.5%
N/A-8.0%£90.60M£136M398.15280
KOD
Kodal Minerals
1.3998 of 5 stars
GBX 0.33
+1.9%
GBX 1.23
+276.9%
-36.6%£67.94MN/A-596.3390Gap Down
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179
AMPH
Aggregated Micro Power
N/AN/AN/AN/A£64.54M£49.33M70.771,620Gap Up

Related Companies and Tools


This page (LON:IGC) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners